Hypertension associated with oral administration of physostigmine in a patient with Alzheimer's disease

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The hemodynamic effects of physostigmine, a cholinomimetic drug used in the experimental treatment of Alzheimer's disease, are largely unknown. The author describes the development of episodes of hypertension in an elderly patient with Alzheimer's disease following treatment with oral physostigmine.

Original languageEnglish (US)
Pages (from-to)910-912
Number of pages3
JournalAmerican Journal of Psychiatry
Volume143
Issue number7
StatePublished - 1986

Fingerprint

Physostigmine
Oral Administration
Alzheimer Disease
Hypertension
Cholinergic Agents
Hemodynamics
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

@article{b8a79f241c0340af8e290e544bee773d,
title = "Hypertension associated with oral administration of physostigmine in a patient with Alzheimer's disease",
abstract = "The hemodynamic effects of physostigmine, a cholinomimetic drug used in the experimental treatment of Alzheimer's disease, are largely unknown. The author describes the development of episodes of hypertension in an elderly patient with Alzheimer's disease following treatment with oral physostigmine.",
author = "Cain, {J. W.}",
year = "1986",
language = "English (US)",
volume = "143",
pages = "910--912",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "7",

}

TY - JOUR

T1 - Hypertension associated with oral administration of physostigmine in a patient with Alzheimer's disease

AU - Cain, J. W.

PY - 1986

Y1 - 1986

N2 - The hemodynamic effects of physostigmine, a cholinomimetic drug used in the experimental treatment of Alzheimer's disease, are largely unknown. The author describes the development of episodes of hypertension in an elderly patient with Alzheimer's disease following treatment with oral physostigmine.

AB - The hemodynamic effects of physostigmine, a cholinomimetic drug used in the experimental treatment of Alzheimer's disease, are largely unknown. The author describes the development of episodes of hypertension in an elderly patient with Alzheimer's disease following treatment with oral physostigmine.

UR - http://www.scopus.com/inward/record.url?scp=0022573591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022573591&partnerID=8YFLogxK

M3 - Article

C2 - 3717434

AN - SCOPUS:0022573591

VL - 143

SP - 910

EP - 912

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 7

ER -